Medtronic, Inc. and Medtronic Sofamor Danek, USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) B ATLANTA, Dec. 3 /PRNewswire/ -- A patient who was surgically implanted ...

June 2 (Reuters) - Managed care company Humana Inc has filed a lawsuit against Medtronic Inc accusing the medical device maker of falsely representing its Infuse bone growth-stimulation product as ...

Minneapolis-based Medtronic faces approximately 700 lawsuits involving 1,000 patients claiming personal injury due to the company’s Infuse bone graft product, according to the company’s SEC filing for ...

In response to a lawsuit filed Dec. 2 in California, Medtronic Inc. issued a statement Wednesday afternoon, denying any wrongdoing in marketing a product that the lawsuit alleged caused the death of a ...

Two patients who were injured by Medtronic's controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor ...

Medtronic Inc. was sued by managed-care company Humana for allegedly marketing its Infuse bone-graft product for uses that weren't approved by regulators and duping the insurer into covering those ...

Medtronic Inc., the second-largest medical device maker, was sued by shareholders over claims it misled investors about the profitability of its Infuse device that stimulates bone growth. The lawsuit, ...

It is estimated that 85% of surgeries using Infuse were performed off-label. Unfortunately, the off-label use of Infuse causes an over-promotion of bone growth which leads to significant nerve damage, ...

MEMPHIS, Tenn.--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today announced that it has received regulatory approval from the U.S. Food and Drug Administration (FDA) to begin marketing INFUSE® Bone ...

A Wall Street analyst is speculating that Medtronic’s woes over its blockbuster Infuse product might lead the medical device company to pull the plug on the entire spinal business. But given the ...